Literature DB >> 2672428

Action of magnesium sulfate in the treatment of preeclampsia-eclampsia.

M Sadeh1.   

Abstract

Recent evidence supports the concept that cerebral vasospasm is involved in the pathogenesis of eclampsia. Magnesium, which has a beneficial effect in eclampsia, may act by opposing calcium-dependent arterial constriction, thereby relieving vasospasm. Magnesium may also antagonize the increase in intracellular calcium concentration caused by ischemia and thus prevent cell damage and death. Magnesium might have a role in the treatment of cerebral vasospasm and ischemia, such as occurs in subarachnoid hemorrhage, ischemic stroke, and brain trauma.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2672428     DOI: 10.1161/01.str.20.9.1273

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  16 in total

1.  Magnesium sulphate and pre-eclampsia. Trial needed to see whether it's as valuable in pre-eclampsia as in eclampsia.

Authors:  L Duley; J P Neilson
Journal:  BMJ       Date:  1999-07-03

Review 2.  Perioperative stroke. Part I: General surgery, carotid artery disease, and carotid endarterectomy.

Authors:  D H Wong
Journal:  Can J Anaesth       Date:  1991-04       Impact factor: 5.063

Review 3.  The neurology of pregnancy.

Authors:  G V Sawle; M M Ramsay
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-06       Impact factor: 10.154

4.  Serum magnesium levels as related to symptomatic vasospasm and outcome following aneurysmal subarachnoid hemorrhage.

Authors:  Frederic P Collignon; Jonathan A Friedman; David G Piepgras; Mark A Pichelmann; Jon I McIver; L Gerard Toussaint; Robyn L McClelland
Journal:  Neurocrit Care       Date:  2004       Impact factor: 3.210

Review 5.  Magnesium sulfate administration in subarachnoid hemorrhage.

Authors:  Jose I Suarez
Journal:  Neurocrit Care       Date:  2011-09       Impact factor: 3.210

Review 6.  Magnesium sulphate versus diazepam for eclampsia.

Authors:  Lelia Duley; David J Henderson-Smart; Godfrey Ja Walker; Doris Chou
Journal:  Cochrane Database Syst Rev       Date:  2010-12-08

Review 7.  Critical care management of patients following aneurysmal subarachnoid hemorrhage: recommendations from the Neurocritical Care Society's Multidisciplinary Consensus Conference.

Authors:  Michael N Diringer; Thomas P Bleck; J Claude Hemphill; David Menon; Lori Shutter; Paul Vespa; Nicolas Bruder; E Sander Connolly; Giuseppe Citerio; Daryl Gress; Daniel Hänggi; Brian L Hoh; Giuseppe Lanzino; Peter Le Roux; Alejandro Rabinstein; Erich Schmutzhard; Nino Stocchetti; Jose I Suarez; Miriam Treggiari; Ming-Yuan Tseng; Mervyn D I Vergouwen; Stefan Wolf; Gregory Zipfel
Journal:  Neurocrit Care       Date:  2011-09       Impact factor: 3.210

8.  Magnesium sulfate treatment in experimental spinal cord injury: emphasis on vascular changes and early clinical results.

Authors:  Erkan Kaptanoglu; Etem Beskonakli; Ihsan Solaroglu; Asuman Kilinc; Yamac Taskin
Journal:  Neurosurg Rev       Date:  2003-05-29       Impact factor: 3.042

9.  Magnesium sulfate treatment improves outcome in patients with subarachnoid hemorrhage: a meta-analysis study.

Authors:  Bin Huang; Nikan H Khatibi; Linyan Tong; Pengcheng Yan; Peng Xie; John H Zhang
Journal:  Transl Stroke Res       Date:  2010-06       Impact factor: 6.829

10.  Intravenous magnesium sulfate administration in a patient with refractory vasospasm following subarachnoid hemorrhage.

Authors:  Maria Barile; Françoise van De Wyngaert; Jean-Jacques Essama Mbia; Mijael Jativa; Cécile Grandin; Herbert Rooijakkers; Philippe Hantson
Journal:  Intensive Care Med       Date:  2003-04-16       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.